R20 mg Kit (10 Vials) – Pre – Order

Description

R20 (Retatrutide) is a next-generation triple-agonist research peptide that has become one of the most talked-about compounds in the space. Designed to engage three key metabolic receptor pathways simultaneously — GLP-1, GIP, and glucagon — R20 has generated significant interest in research communities studying metabolic regulation, energy balance, and body composition.

This is one of the most anticipated group buys we’ve run, and for good reason.

🔬 Key Research Areas

• Triple-Receptor Activation — R20 engages GLP-1R, GIPR, and GCGR receptors simultaneously, making it a uniquely multi-pathway compound in current metabolic research
• Metabolic Regulation — Studied in models exploring glucose metabolism, appetite signaling, and energy expenditure
• Body Composition Research — Among the most researched next-generation peptides for fat metabolism and weight regulation models
• Energy Balance Modeling — Researchers investigate how coordinated receptor activation influences overall systemic energy balance

📦 Group Buy Information

• Pre-Order Window: April 30 – May 10 8 pm CT
• MOQ: 20 Kits — this buy only moves forward if we hit 20
• Full Kits Only
• Third-Party Testing: Janoshik testing included

If MOQ isn’t met by May 10, we will evaluate next steps — which may include a short extension. The goal is to hit it strong and on time.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For research purposes only.